NYMX Nymox Pharmaceutical Corporation

1.68
-0.05  -3%
Previous Close 1.73
Open 1.75
Price To Book 11.2
Market Cap 114,115,680
Shares 67,926,000
Volume 103,583
Short Ratio
Av. Daily Volume 92,922

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Data released February 2016 met endpoint
NX-1207 long-term NX03-0040 trial
Low grade localized prostate cancer
NDA filing due later in 2019.
NX-1207 Fexapotide
BPH